Proceedings of the Standing Senate Committee on
Social Affairs, Science and Technology

Issue 20 - Minutes of Proceedings - October 1, 2014

OTTAWA, Wednesday, October 1, 2014
(44)

[English]

The Standing Senate Committee on Social Affairs, Science and Technology met this day at 4:13 p.m., in room 2, Victoria Building, the chair, the Honourable Kelvin Kenneth Ogilvie, presiding.

Members of the committee present: The Honourable Senators Chaput, Cordy, Eggleton, P.C., Enverga, Nancy Ruth, Ogilvie, Seidman, Seth and Stewart Olsen (9).

In attendance: Sonya Norris, Analyst, Parliamentary Information and Research Service.

Also in attendance: The official reporters of the Senate.

Pursuant to the order of reference adopted by the Senate on Thursday, September 18, 2014, the committee continued its study of Bill C-17, An Act to amend the Food and Drugs Act. (For complete text of the order of reference, see proceedings of the committee, Issue No. 19).

WITNESSES:

Canadian Generic Pharmaceutical Association:

Jim Keon, President.

Consumer Health Products Canada:

Gerry Harrington, Director of Public Affairs.

MEDEC:

Klaus Stitz, Vice President, Regulatory Affairs.

Rx&D:

Walter Robinson, Vice President, Government Relations;

Jared Rhines, Vice President, Scientific and Strategic Affairs.

The chair made a statement

Mr. Keon, Mr. Harrington, Mr. Stitz, Mr. Rhines and Mr. Robinson each made a statement and, together, answered questions.

At 5:59 p.m., the committee adjourned to the call of the chair.

ATTEST:

Jessica Richardson

Clerk of the Committee